National Institute for Health and Clinical Excellence (NICE)
NICE and PHE recommend all employers give mental health training for managers
All managers should be given the skills to support employees with mental health issues, NICE and PHE have said in new guidance.
Reducing stigma and equipping managers with skills to have conversations with employees about mental health is likely to facilitate conversations that address concerns about their mental wellbeing, the guideline says.
NICE and Public Health England’s guideline on Mental Wellbeing at Work covers how to create the right conditions to support mental wellbeing at work through an environment and culture of participation, equality, safety and fairness in the workplace based on open communication.
The independent guideline committee, made up of mental health experts, employers, professionals from across the NHS, local authority members, and lay members, recommended when offering mental health training for managers, employers should consider including:
- how to have a conversation about mental wellbeing with an employee
- information about mental wellbeing
- how to identify early warning signs of poor mental wellbeing
- resources on mental wellbeing
- awareness of the stigma associated with poor mental wellbeing
- ongoing monitoring of mental wellbeing in the workplace
The guideline says the training should equip managers with the knowledge, tools, skills and resources to improve awareness of mental wellbeing at work. It should also improve employees’ understanding of and engagement in organisational decisions and the communication between managers and employees.
Dr Paul Chrisp, director of NICE’s centre for guidelines, said: “Even before the pandemic, the state of the nation’s mental health has been a topic of conversation at home, in the workplace and in the media.
“Our new guideline has considered issues which were a problem before COVID-19 emerged and new issues which have presented themselves as a result of the pandemic.
“Reducing stigma and equipping managers with skills to have conversations with employees about mental health is likely to facilitate conversations between managers and employees about any concerns about their mental wellbeing. This makes it more likely that managers can support employees with mental health issues.
“Further research is needed in this area, but providing managers with skills to discuss mental wellbeing improves the relationship between manager and employee so that they can identify and reduce work stressors.
“This is a practicable step employers can implement and adopted quickly without a huge amount of investment.”
The committee agreed that it was important that all line managers received training and support. They considered that this was good practice in all industries and all sizes of organisation, and that managers benefit in terms of their mental wellbeing from feeling skilled to perform their line management duties.
A Deloitte report, Mental health and employers | Refreshing the case for investment published in January 2020, estimates that poor mental health among employees costs UK employers £42bn – £45bn each year. This is made up of absence costs of around £7bn, presenteeism coming to work despite poor health and underperforming- costs ranging from about £27bn to £29bn and turnover costs of around £9bn. This is an increase of about 6bn and 16% on the figures in their our 2017 report, driven primarily by a rise in presenteeism.
Latest News from
National Institute for Health and Clinical Excellence (NICE)
NICE announces next steps for publication of its guideline on ME/CFS20/10/2021 14:20:00
NICE has today (20 October 2021) announced the next steps for publication of its updated guideline on the diagnosis and management of myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS)
New draft guideline to help reduce health inequalities in people experiencing homelessness07/10/2021 09:15:00
NICE and the Centre for Homelessness Impact (CHI) have jointly published a new draft guideline to increase the access people experiencing homelessness have to health and social care services and improve their health outcomes.
NICE updates managing COVID guideline with new monoclonal antibody recommendations06/10/2021 11:15:00
NICE has updated its managing COVID-19 guideline to include new recommendations on using monoclonal antibodies to treat COVID-19 patients in hospital.
NICE recommends first treatment in two decades for sickle cell disease05/10/2021 11:15:00
Hundreds of people will be eligible for a new treatment for sickle cell disease following draft guidance published today (5 October).
People with advanced or metastatic urothelial cancer to get life-extending treatment01/10/2021 11:15:00
Around 130 people per year with untreated locally advanced or metastatic urothelial cancer will be eligible for a new life-extending treatment after NICE published final draft guidance yesterday (30 September 2021) recommending atezolizumab.
Update on the NICE ME/CFS guideline roundtable discussion22/09/2021 09:10:00
The roundtable meeting to discuss the updated guideline on the diagnosis and management of ME/CFS will be held on October 18th in London. It is being convened after publication of the guideline was paused when issues were raised by some professional groups during the pre-publication period
NICE recommends treatment for people with juvenile idiopathic arthritis10/09/2021 11:15:00
NICE yesterday (9 September 2021) published final draft guidance which recommends tofacitinib (also known as Xeljanz and made by Pfizer) as an option for treating active polyarticular juvenile arthritis and juvenile psoriatic arthritis in people 2 years and older.
Professor Gillian Leng to retire from NICE09/09/2021 14:15:00
Professor Leng has spent more than 20 years working at NICE.
NICE draft guidance recommends apalutamide for treating prostate cancer08/09/2021 12:20:00
NICE has today (8 September 2021) published final draft guidance which now recommends apalutamide (also called Erleada and made by Janssen) plus androgen deprivation therapy for treating prostate cancer in adults